Importance of factor Xa in determining the procoagulant activity of whole-blood clots.

Yazar: Eisenberg, P R, Siegel, J E, Abendschein, D R, Miletich, J P
Baskı/Yayın Bilgisi 1993

Randomised, phase II trial comparing oral capecitabine (Xeloda®) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines

Yazar: Talbot, D C, Moiseyenko, V, Van Belle, S, O'Reilly, S M, Alba Conejo, E, Ackland, S, Eisenberg, P, Melnychuk, D, Pienkowski, T, Burger, H-U, Laws, S, Osterwalder, B
Baskı/Yayın Bilgisi 2002

Study of autologous dendritic cell therapy targeting Mucin 1 as a treatment for the maintenance of ovarian cancer patients in remission

Yazar: Goh, J, Mason, J, Chan, J, Moradi, M, Berek, J, Beningno, B, Mileshkin, L, Recio, F, Tchabo, N, Rossi, E, Eisenberg, P, Rose, P, Mitchell, P, Young, J, Matos, M, Secord, A, Davy, M, Gargosky, S, Gray, H
Baskı/Yayın Bilgisi 2013